News
3d
Zacks.com on MSNExploring CVS' Health Services Segment: A Key Growth Engine for 2025?CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.
The healthcare sector is dominated by massive players, but few are as influential as UnitedHealth Group Incorporated UNH and ...
5d
Zacks.com on MSNNovo Nordisk Stock Rises 6% in a Week: What Should Investors Do?NVO jumps nearly 6% in a week on amycretin pipeline boost and hedge fund interest, but competition looms large.
1d
Zacks Investment Research on MSNLLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?Eli Lilly LLY and AbbVie ABBV are U.S.-based pharmaceutical powerhouses with blockbuster drug portfolios, robust pipelines, ...
4d
Zacks Investment Research on MSNCVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy?CVS Health CVS has seen its stock surge by 53.7% in 2025, fueled by a potent combination of strong operational performance ...
However, it is not the first alliance between the two companies. COVID accelerated coalitions In 2008, CVS Caremark, a prescription benefit management company, signed on to use Microsoft's ...
Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo Nordisk, after negotiating a price cut with the company, along with Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results